Taking people in GermanyNo phase
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Key facts
- Where
- Munich, GermanySee the site
Where in Germany
- Institut für Diabetesforschung, Helmholtz Zentrum MünchenMunich, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Helmholtz Zentrum München
- Trial code
- NCT03316261
- Record updated
- 17 December 2024
- Original description
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.Read full original descriptionShow less
Freder1k-Study - Identification of Infants With Increased Type 1 Diabetes Risk for Enrollment Into Primary Prevention Trials
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
Inclusion: Age: up to age 6 weeks; provided written informed consent by custodial parent.
Exclusion: -.